Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADAPT: Individualized Rosuvastatin Dosing in Type 2 Diabetes
NCT00747149Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- May 2008
- Primary completion
- Aug 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin in hypercholesterolemia, sponsored by AstraZeneca. Started May 2008; status: completed.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00747149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00747149.